Avadel Pharmaceuticals's total assets for Q4 2024 were $164.24M, an increase of 3.78% from the previous quarter. AVDL total liabilities were $90.39M for the fiscal quarter, a 8.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.